Marcia Simmonds
Family · Minneapolis, MNNPI 1295914638
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 120 payments — averaging $81.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Jazz Pharmaceuticals Inc.$1K
- E.r. Squibb & Sons, L.L.C.$843
- GSK$599
- Johnson & Johnson$594
- Daiichi Sankyo Inc.$533
- plus $5K from 28 others
What the payments were for
- Food & beverage$9,738100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 10 | $1,177 |
| Jazz Pharmaceuticals Inc. | 10 | $1,169 |
| E.r. Squibb & Sons, L.L.C. | 7 | $843 |
| GSK | 5 | $599 |
| Johnson & Johnson(2 entities) | 6 | $594 |
| Daiichi Sankyo Inc. | 5 | $533 |
| Genentech USA, Inc. | 5 | $476 |
| Boehringer Ingelheim | 19 | $382 |
| Eisai Inc. | 3 | $353 |
| Sanofi | 2 | $254 |
| Stemline Therapeutics Inc. | 3 | $243 |
| Genmab U.S., Inc. | 2 | $239 |
| Gilead | 2 | $225 |
| Puma Biotechnology, Inc. | 3 | $221 |
| Incyte Corporation | 2 | $217 |
| Ipsen Biopharmaceuticals, Inc | 2 | $212 |
| Seagen Inc. | 2 | $206 |
| Beigene USA, Inc. | 2 | $188 |
| Merck | 7 | $166 |
| Legend Biotech USA Inc. | 1 | $139 |
| Boston Scientific | 7 | $128 |
| Bayer | 1 | $125 |
| EMD Serono, Inc. | 1 | $125 |
| Pfizer | 1 | $125 |
| GT Medical Technologies, Inc | 1 | $123 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| AbbVie | 1 | $120 |
| Servier Pharmaceuticals LLC | 1 | $112 |
| Amgen | 2 | $111 |
| Lilly USA, LLC | 1 | $90 |
| Stryker | 1 | $46 |
| Abbott | 2 | $44 |
| Siemens Medical Solutions USA, Inc. | 1 | $20 |
| Edwards Lifesciences | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,738 in reported general payments places this provider in the 95th percentile of 1,121 family providers in Minnesota.
Other family in Minneapolis
- Julia GourdeMinneapolis$65K
- Robin DontaMinneapolis$60K
- Kristin WeberMinneapolis$35K
- Kathleen FredellMinneapolis$28K
- Diana CzelMinneapolis$24K
- Elisa RiveroMinneapolis$16K
- Rachel StenachMinneapolis$7K
- Regina SoehnleinMinneapolis$5K
- Kathryn TietzMinneapolis$3K
- Ashley EnglishMinneapolis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.